Back to search

Pyrinome Therapeutics Limited

15424027

active
Private Limited Company
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

THE OCTAGON SUITE E2, 2ND FLOOR, COLCHESTER, CO1 1TG
Incorporated 18/01/2024

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Professor Anthony Segal

director · Since 18/01/2024

DIRECTOR

BRITISH · ENGLAND · Age 82

Ben Stephens

secretary · Since 02/09/2024

Albert Meyer Corin

director · Since 02/09/2024

DIRECTOR

BRITISH · UNITED KINGDOM · Age 60

Also on 1 other board

Persons with Significant Control

Professor Anthony Segal

50–75% shares
50–75% votes
Appoint directors

British · England · Age 82

The Octagon, Suite E2, 2nd Floor, Colchester, CO1 1TG

Notified 18/01/2024

CompanyRankvs 1500+ SIC 72110 peers
56

Financial strength81th percentile among SIC peers · 20/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 1.96× · 16/20
Longevity2 years trading (max 15) · 2/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength20/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity16/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity2/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/01/2025

Net Worth

£123k

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

£123k

Working capital

Current Assets

£251k

Current Liabilities

£128k

0avg. employees

Balance Sheet

Assets less current liabilities£123k
Prepared with Taxfiler

EstimatesDerived

YearCurrent Ratio
20251.96

Derived from filed accounts. Not audited figures.